S3 Group

Therapy and Medication Adherence Programs

Patient adherence is not an on/off switch. Reminders, traditional education or occasional coaching can help, but won’t solve the problem of non-adherence.

Patient Adherence

Solving the problem of non-adherence

Adherence relates to how each individual thinks, behaves, and engages with their therapy and medication. Solving the problem of non-adherence involves the patient, the caregiver, the healthcare provider, pharmaceutical companies and payors.

S3 Connected Health develops hyper-personalized digital patient adherence programs, led by evidence-based and validated behavior change models. By factoring in real world circumstances, our programs can improve adherence and healthcare outcomes.

Improvement

Challenges and Benefits of Improving Adherence

Medication-taking behavior is highly complex and individual, so multifactorial strategies are needed to improve adherence to therapies.

Patients

Patients

To address non-adherence effectively, patients must be active partners in their own care. They must feel informed, empowered and their perspective and perceptions have to been taken into account. Only by focusing on these needs can patients’ motivations to managing their disease, and adherence to their therapy, be addressed.

Clinicians

Clinicians

Because patients recall as little as 50% of what is discussed during consultations, programs addressing non-adherence must go beyond the clinician's office and into the patient’s day-to-day life in order to address the practicalities affecting a patient’s ability to adhere.

Healthcare Providers, Pharmaceutical Companies, Payors, and Care Givers

Healthcare Providers, Pharmaceutical Companies, Payors, and Care Givers

Adherence is not exclusively the responsibility of the patient. Adherence programs must address both the motivations and the practicalities of the many stakeholders involved. From providing access to medication, delivery of support and care, through to looking at each individuals’ circumstances.

Patients

Patients

To address non-adherence effectively, patients must be active partners in their own care. They must feel informed, empowered and their perspective and perceptions have to been taken into account. Only by focusing on these needs can patients’ motivations to managing their disease, and adherence to their therapy, be addressed.

Clinicians

Clinicians

Because patients recall as little as 50% of what is discussed during consultations, programs addressing non-adherence must go beyond the clinician's office and into the patient’s day-to-day life in order to address the practicalities affecting a patient’s ability to adhere.

Healthcare Providers, Pharmaceutical Companies, Payors, and Care Givers

Healthcare Providers, Pharmaceutical Companies, Payors, and Care Givers

Adherence is not exclusively the responsibility of the patient. Adherence programs must address both the motivations and the practicalities of the many stakeholders involved. From providing access to medication, delivery of support and care, through to looking at each individuals’ circumstances.

How We Do It

S3 Connected Health has extensive experience and expertise in delivering personalized healthcare through medication adherence technology, drug adherence programs and interventions to improve medication adherence

Hyper-Personalized

Hyper-Personalized

Our digital, patient centered solutions enable hyper-personalized support, at all stages of the therapy life-cycle, to provide the right intervention, at the right time given each person’s specific circumstances.

Evidence-based Behavior Change

Evidence-based Behavior Change

Because adherence relates to a person’s behavior, we implement validated, evidence-based behavior change models that optimize interventions, form positive habits around a patient’s condition, and improve healthcare outcomes.

Multi-factorial, Multiple Stakeholders

Multi-factorial, Multiple Stakeholders

We know that the range of factors affecting adherence are complex, relate to the individual, and involve multiple stakeholders. That’s why we have processes in place to identify and address the drivers and barriers of individual people effectively and in a regulatory compliant way.

Population Health Monitoring

Population Health Monitoring

Our solutions use predictive analytics and data capture to enable monitoring of patient cohorts across borders, predicting potential changes in adherence, and adapting based on latest information.

Our Platform

Find out how our Affinial platform addresses the full range of factors affecting a patient’s adherence to their therapy and medication

Find Out More

Customizable

Designing Programs to Meet Your Needs

S3 Connected Health looks at the challenges each condition presents, and designs programs to address these for the patient, our pharmaceutical partners, healthcare providers and for payors.

We are driven to meet the goals and needs of brand managers throughout the product lifecycle.

  • Comprehensive digital strategy for new product launch
  • Market access strategies, with supporting patient programs and Real-World Evidence
  • Supporting Risk Evaluation and Mitigation Strategies (REMs)
  • Therapy adherence programs for medication regimes
  • Implementing a multi-therapy program to generate cross territory evidence
  • Managing a brand switching strategy and supporting programs
  • Comprehensive and consistent programs for sparse and geographically widespread patient populations
  • Patent expiration strategies for brand differentiation

Discover More

Call one of our experts to discuss your needs and find the right solutions for your challenges.

Contact Us
This website uses cookies

We use cookies to improve your experience of our website, If you continue to use our site we will assume that you are happy to receive all our cookies to measure the audience and to offer you suitable services and adverts.

Okay ×